KOPRAN
|
KOPRAN Last 5 Year Cashflow Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit Before Tax | ₹52 Cr | ₹68 Cr | ₹36 Cr | ₹82 Cr | ₹83 Cr |
Adjustment | ₹25 Cr | ₹21 Cr | ₹16 Cr | ₹14 Cr | ₹16 Cr |
Changes In working Capital | ₹-22 Cr | ₹-31 Cr | ₹-5.55 Cr | ₹-111 Cr | ₹-24 Cr |
Cash Flow after changes in Working Capital | ₹55 Cr | ₹58 Cr | ₹47 Cr | ₹-15 Cr | ₹76 Cr |
Cash Flow from Operating Activities | ₹42 Cr | ₹43 Cr | ₹34 Cr | ₹-33 Cr | ₹60 Cr |
Cash Flow from Investing Activities | ₹-56 Cr | ₹-44 Cr | ₹-13 Cr | ₹-84 Cr | ₹-25 Cr |
Cash Flow from Financing Activities | ₹26 Cr | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr |
Net Cash Inflow / Outflow | ₹11 Cr | ₹0.69 Cr | ₹1.53 Cr | ₹4.93 Cr | ₹0.10 Cr |
Opening Cash & Cash Equivalents | ₹8.09 Cr | ₹7.40 Cr | ₹5.87 Cr | ₹0.94 Cr | ₹0.83 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹19 Cr | ₹8.09 Cr | ₹7.40 Cr | ₹5.87 Cr | ₹0.94 Cr |
Compare Cashflow Statement of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹808.3 Cr | -3.8% | -5.8% | -43.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,218.0 Cr | -0.7% | 3% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,158.0 Cr | 1.9% | 8.3% | 5.8% | Stock Analytics | |
CIPLA | ₹126,710.0 Cr | 0.5% | 0.7% | -2.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,586.0 Cr | -0.1% | NA | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,496.0 Cr | -2% | -5.4% | -7.5% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -3.8% |
-5.8% |
-43.5% |
SENSEX | 1.6% |
2.1% |
2.6% |
You may also like the below Video Courses